FIELD: medicine, pharmaceutics.
SUBSTANCE: invention discloses a combination preparation for increasing the potency of vaccines containing an antigen. The preparation contains synthetic glycolipid PBS-57 and the vaccine. The ingredients of the combination preparation may be used both together, and successively. The preparation under the invention is administered intravenously, intracutaneously, subcutaneously and by any other known ways. Glyolipid PBS-57 is an adjuvant with a reduced number of side actions and in the meantime promotes the development of a durable protective immunity.
EFFECT: administered preparation promotes the humoral immune response to a vaccine antigen in an individual, particularly provides increasing the production of IgG, IgA and/or IgM antibodies, activates CD4+ T lymphocytes and CD8+ cytotoxic lymphocytes in the individual.
10 cl, 16 dwg, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO ANTIGENS | 2008 |
|
RU2537188C2 |
| ENHANCING IMMUNE RESPONSE AND TARGET FOCUS BY ANTIGENS AND/OR DRUG | 2008 |
|
RU2548685C2 |
| VACCINE BASED ON B-CELLS, LOADED WITH LIGANDS OF T-CELLS-NATURAL KILLERS AND ANTIGEN | 2006 |
|
RU2420311C2 |
| AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
| IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
| IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
| ANTIGENIC COMPOSITION FOR INDUCING CYTOTOXIC T-LYMPHOCYTES RESPONSE, METHOD OF INDUCTION AND METHOD OF PATIENTS TREATMENT | 1992 |
|
RU2129439C1 |
| VECTORS FOR DELIVERY OF MOLECULES TO CD11b-EXPRESSING CELLS | 2001 |
|
RU2312143C2 |
| MICROFLUIDIZED COMPOSITION FOR INDUCTION OF SPECIFIC CYTOTOXIC T-LYMPHOCYTE IMMUNE RESPONSE AND ITS USING FOR DISEASE TREATMENT | 1995 |
|
RU2201253C2 |
| COMPLEX CONTAINING AN OLIGONUCLEOTIDE, HAVING IMMUNOSTIMULATING ACTIVITY, AND ITS APPLICATION | 2014 |
|
RU2723943C2 |
